Going beyond insulin in type 1 diabetes: A new wave of disease-modifying therapies By Samuel J. Reich, CEO, SAB Biotherapeutics, Inc.June 1, 2026 This post is sponsored by SAB Biotherapeutics, Inc.

https://www.statnews.com/sponsor/2026/06/01/going-beyond-insulin-in-type-1-diabetes-a-new-wave-of-disease-modifying-therapies/